These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Marshall JK; Irvine EJ Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961 [TBL] [Abstract][Full Text] [Related]
10. Ulcerative proctitis: a review of pharmacotherapy and management. Lakatos PL; Lakatos L Expert Opin Pharmacother; 2008 Apr; 9(5):741-9. PubMed ID: 18345952 [TBL] [Abstract][Full Text] [Related]
11. Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis. Harris MS; Lichtenstein GR Aliment Pharmacol Ther; 2011 May; 33(9):996-1009. PubMed ID: 21385194 [TBL] [Abstract][Full Text] [Related]
12. [Guidelines of the DGVS. Acute process. German Society of Digestive and Metabolic Diseases]. Fleig WE; Z Gastroenterol; 2001 Jan; 39(1):33-8. PubMed ID: 11215362 [No Abstract] [Full Text] [Related]
17. Long-term intermittent treatment with low-dose 5-aminosalicylic enemas is efficacious for remission maintenance in ulcerative colitis. Piodi LP; Ulivieri FM; Cermesoni L; Cesana BM Scand J Gastroenterol; 2004 Feb; 39(2):154-7. PubMed ID: 15000277 [TBL] [Abstract][Full Text] [Related]
18. [Budesonide foam as a new therapeutic principle in distal ulcerative colitis in comparison with mesalazine enema. An open, controlled, randomized and prospective multicenter pilot study]. Rufle W; Frühmorgen P; Huber W; Kimmig JM Z Gastroenterol; 2000 Apr; 38(4):287-93. PubMed ID: 10820860 [TBL] [Abstract][Full Text] [Related]
19. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease. Segars LW; Gales BJ Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685 [TBL] [Abstract][Full Text] [Related]
20. [Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH]. Dejaco C; Haas T; Kirchgatterer A; Miehsler W; Wenzl H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W; Tilg H Z Gastroenterol; 2006 Jun; 44(6):525-38; discussion 539. PubMed ID: 16773519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]